https://www.biopharmawatch.com/news/MODD/modular-medical-webinar-launch-pivot
BiopharmaWatch
en
2026-09-04T00:00:00.000Z
Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday, September 4, 2026
https://www.biopharmawatch.com/news/MIST/milestone-pharmaceuticals-nmpa-approval-etripamil-china
BiopharmaWatch
en
2026-09-03T13:35:00.000Z
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
https://www.biopharmawatch.com/news/COSM/cosmos-health-transformation-2026
BiopharmaWatch
en
2026-09-03T13:30:00.000Z
Cosmos Health: A Company Transformed — 2026 Year-to-Date
https://www.biopharmawatch.com/news/ABBV/abbvie-phase-3-cervino-trial-results-etentamig
BiopharmaWatch
en
2026-09-03T13:15:00.000Z
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
https://www.biopharmawatch.com/news/LGVN/longeveron-hc-wainwright-investment-conference-2026
BiopharmaWatch
en
2026-09-03T13:15:00.000Z
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/HCTI/hcti-distributes-minority-interest-teyame-ai-holdings
BiopharmaWatch
en
2026-09-03T13:05:00.000Z
Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing.
https://www.biopharmawatch.com/news/LIVN/livanova-presents-morgan-stanley-baird-conferences-september
BiopharmaWatch
en
2026-09-03T13:00:00.000Z
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September
https://www.biopharmawatch.com/news/CYH/community-health-systems-2026-impact-report
BiopharmaWatch
en
2026-09-03T13:00:00.000Z
Community Health Systems Releases 2026 Community Impact Report
https://www.biopharmawatch.com/news/ALC/alcon-launches-unity-m-ophthalmic-microscope
BiopharmaWatch
en
2026-09-03T13:00:00.000Z
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
https://www.biopharmawatch.com/news/CODX/co-diagnostics-cloud-infrastructure-india
BiopharmaWatch
en
2026-09-03T13:00:00.000Z
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
https://www.biopharmawatch.com/news/PALI/palisade-bio-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-03T13:00:00.000Z
Palisade Bio to Participate in Upcoming Investor Conferences
https://www.biopharmawatch.com/news/PLRZ/polyrizon-4-million-offering-private-placement
BiopharmaWatch
en
2026-09-03T12:50:00.000Z
Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
https://www.biopharmawatch.com/news/APGE/abbvie-completes-acquisition-apogee-therapeutics
BiopharmaWatch
en
2026-09-03T12:34:00.000Z
AbbVie Completes Acquisition of Apogee Therapeutics
https://www.biopharmawatch.com/news/CTXR/citius-pharmaceuticals-september-2026-investor-conferences
BiopharmaWatch
en
2026-09-03T12:30:00.000Z
Citius Pharmaceuticals to Participate in September 2026 Investor Conferences
https://www.biopharmawatch.com/news/TLPH/talphera-hc-wainwright-investment-conference-2026
BiopharmaWatch
en
2026-09-03T12:30:00.000Z
Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/FBLG/fibrobiologics-new-patent-fibroblasts-wound-healing
BiopharmaWatch
en
2026-09-03T12:30:00.000Z
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
https://www.biopharmawatch.com/news/KALA/kala-virotek-exclusive-distribution-agreement
BiopharmaWatch
en
2026-09-03T12:30:00.000Z
Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
https://www.biopharmawatch.com/news/BBLG/bone-biologics-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-03T12:30:00.000Z
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/NXL/nexalin-technology-alzheimers-study-analysis
BiopharmaWatch
en
2026-09-03T12:30:00.000Z
Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer’s Pilot Study
https://www.biopharmawatch.com/news/CRVS/corvus-pharmaceuticals-2026-cantor-conference
BiopharmaWatch
en
2026-09-03T12:30:00.000Z
Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/MDLN/medline-participation-morgan-stanley-healthcare-conference
BiopharmaWatch
en
2026-09-03T12:30:00.000Z
Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
https://www.biopharmawatch.com/news/ONCO/onconetix-acquisition-realbotix-humanoid-robots-pilot
BiopharmaWatch
en
2026-09-03T12:30:00.000Z
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events
https://www.biopharmawatch.com/news/PROF/profound-medical-lake-street-conference-2026
BiopharmaWatch
en
2026-09-03T12:15:00.000Z
Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
https://www.biopharmawatch.com/news/SRXH/srx-global-armr-sciences-shareholder-update
BiopharmaWatch
en
2026-09-03T12:15:00.000Z
SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
https://www.biopharmawatch.com/news/ABBV/abbvie-presents-morgan-stanley-healthcare-conference-2026
BiopharmaWatch
en
2026-09-03T12:05:00.000Z
AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
https://www.biopharmawatch.com/news/HRMY/harmony-biosciences-poster-presentations-european-epilepsy-congress
BiopharmaWatch
en
2026-09-03T12:05:00.000Z
Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
https://www.biopharmawatch.com/news/SXTP/60-degrees-pharmaceuticals-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-03T12:04:00.000Z
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/ANIX/anixa-biosciences-presentation-nasdaq-ld-micro-summit
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
https://www.biopharmawatch.com/news/MENS/jyong-biotech-stockfan-virtual-investor-roadshow
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Jyong Biotech Announces Participation in StockFan Virtual Investor Non-Deal Roadshow
https://www.biopharmawatch.com/news/NSPR/inspiremd-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/REPL/replimune-present-cantor-global-healthcare-conference-2026
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Replimune to Present at the Cantor Global Healthcare Conference 2026
https://www.biopharmawatch.com/news/TECX/tectonic-therapeutic-morgan-stanley-conference
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference
https://www.biopharmawatch.com/news/LBRX/lb-pharmaceuticals-appoints-joseph-miller-cfo
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer
https://www.biopharmawatch.com/news/NVCT/nuvectis-pharma-investor-conferences-2026
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Nuvectis Pharma To Participate in Upcoming Investor Conferences
https://www.biopharmawatch.com/news/BMEA/biomea-fusion-investor-conferences-2026
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Biomea Fusion to Participate in Upcoming Investor Conferences
https://www.biopharmawatch.com/news/CVKD/cadrenal-therapeutics-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/OVID/ovid-therapeutics-investor-conferences-2026
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Ovid Therapeutics to Participate in Upcoming Investor Conferences
https://www.biopharmawatch.com/news/ALT/altimmune-wells-fargo-healthcare-conference-2026
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference
https://www.biopharmawatch.com/news/QNCX/quince-therapeutics-september-2026-investor-conferences
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Quince Therapeutics to Participate in September 2026 Investor Conferences
https://www.biopharmawatch.com/news/ACRS/aclaris-therapeutics-2026-cantor-conference
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/KRYS/krystal-biotech-2026-cantor-conference
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/GRCE/grace-therapeutics-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-03T12:00:00.000Z
Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/STXS/university-szeged-robotic-cardiology-program-launch
BiopharmaWatch
en
2026-09-03T11:56:00.000Z
University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program
https://www.biopharmawatch.com/news/EBS/emergent-biosolutions-repurchases-senior-unsecured-notes
BiopharmaWatch
en
2026-09-03T11:45:00.000Z
Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes
https://www.biopharmawatch.com/news/HELP/helus-pharma-cantor-healthcare-conference-2026
BiopharmaWatch
en
2026-09-03T11:30:36.000Z
Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York
https://www.biopharmawatch.com/news/LQDA/fda-fast-track-yutrepia-raynauds-phenomenon
BiopharmaWatch
en
2026-09-03T11:30:00.000Z
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
https://www.biopharmawatch.com/news/ARWR/arrowhead-pharmaceuticals-september-2026-investor-conferences
BiopharmaWatch
en
2026-09-03T11:30:00.000Z
Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences
https://www.biopharmawatch.com/news/GPCR/structure-therapeutics-upcoming-healthcare-conferences
BiopharmaWatch
en
2026-09-03T11:30:00.000Z
Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
https://www.biopharmawatch.com/news/DYN/dyne-therapeutics-preclinical-data-dmd-nmsg-meeting
BiopharmaWatch
en
2026-09-03T11:30:00.000Z
Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
https://www.biopharmawatch.com/news/EIKN/eikon-therapeutics-appoints-ching-pin-chang-cso
BiopharmaWatch
en
2026-09-03T11:30:00.000Z
Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer
https://www.biopharmawatch.com/news/ADCT/adc-therapeutics-2026-cantor-global-healthcare-conference
BiopharmaWatch
en
2026-09-03T11:15:00.000Z
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/ATHE/alterity-therapeutics-fireside-chat-cantor-conference-2026
BiopharmaWatch
en
2026-09-03T11:05:00.000Z
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
https://www.biopharmawatch.com/news/CTSO/cytosorbents-reverse-stock-split-nasdaq-compliance
BiopharmaWatch
en
2026-09-03T11:00:00.000Z
CytoSorbents Announces Reverse Stock Split
https://www.biopharmawatch.com/news/INSM/insmed-data-presentation-ers-congress-2026
BiopharmaWatch
en
2026-09-03T11:00:00.000Z
Insmed to Present Data Across Its Respiratory Portfolio, Including New Late-Breaking ARIKAYCE® (amikacin liposome inhalation suspension) Results From Phase 3b ENCORE Study at the European Respiratory Society Congress 2026
https://www.biopharmawatch.com/news/ARMP/armata-pharmaceuticals-phage-biology-publication
BiopharmaWatch
en
2026-09-03T11:00:00.000Z
Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials
https://www.biopharmawatch.com/news/FATE/fate-therapeutics-fireside-chat-2026-cantor-conference
BiopharmaWatch
en
2026-09-03T11:00:00.000Z
Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/ELDN/eledon-pharmaceuticals-islet-cell-transplantation-ind-submission
BiopharmaWatch
en
2026-09-03T11:00:00.000Z
Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial in Fourth Quarter 2026
https://www.biopharmawatch.com/news/GYRE/gyre-therapeutics-september-investor-conferences
BiopharmaWatch
en
2026-09-03T11:00:00.000Z
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
https://www.biopharmawatch.com/news/CCCC/c4-therapeutics-cemsidomide-biomarker-data-presentation
BiopharmaWatch
en
2026-09-03T11:00:00.000Z
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting
https://www.biopharmawatch.com/news/LONA/leonabio-participate-cantor-global-healthcare-conference-2026
BiopharmaWatch
en
2026-09-03T11:00:00.000Z
LeonaBio to Participate in Cantor Global Healthcare Conference 2026
https://www.biopharmawatch.com/news/CLYM/climb-bio-clym116-phase-1-data-iga-nephropathy
BiopharmaWatch
en
2026-09-03T11:00:00.000Z
Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy
https://www.biopharmawatch.com/news/BLSM/blossomhill-therapeutics-conference-presentation
BiopharmaWatch
en
2026-09-03T11:00:00.000Z
BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/ANIP/ani-pharmaceuticals-september-investor-conferences
BiopharmaWatch
en
2026-09-03T10:55:00.000Z
ANI Pharmaceuticals to Present at September Investor Conferences
https://www.biopharmawatch.com/news/PHVS/pharvaris-bradykinin-symposium-2026-data
BiopharmaWatch
en
2026-09-03T10:50:00.000Z
Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026
https://www.biopharmawatch.com/news/FTRE/fortrea-worldwide-clinical-trials-partnership
BiopharmaWatch
en
2026-09-03T07:52:00.000Z
Fortrea เข้าซื้อกิจการหน่วยเภสัชวิทยาคลินิกและการปฏิบัติการห้องปฏิบัติการวิเคราะห์ทางชีวภาพจาก Worldwide Clinical Trials
https://www.biopharmawatch.com/news/FTRE/fortrea-acquires-early-phase-services-worldwide-clinical-trials
BiopharmaWatch
en
2026-09-03T07:52:00.000Z
Fortrea Akan Mengambil Alih Unit Farmakologi Klinikal dan Operasi Makmal Bioanalisis daripada Worldwide Clinical Trials
https://www.biopharmawatch.com/news/FTRE/fortrea-worldwide-clinical-trials-collaboration
BiopharmaWatch
en
2026-09-03T07:52:00.000Z
Fortrea, Worldwide Clinical Trials의 임상약리 유닛·생물분석 연구소 사업 인수
https://www.biopharmawatch.com/news/FTRE/fortrea-acquires-early-phase-services-worldwide
BiopharmaWatch
en
2026-09-03T07:52:00.000Z
Fortrea Akan Mengakuisisi Unit Farmakologi Klinis dan Operasional Laboratorium Bionalitik dari Worldwide Clinical Trials
https://www.biopharmawatch.com/news/FTRE/fortrea-acquires-worldwide-clinical-trials-early-phase-services
BiopharmaWatch
en
2026-09-03T07:52:00.000Z
Fortrea acquiert l’unité de pharmacologie clinique et les activités de laboratoire bioanalytique de Worldwide Clinical Trials
https://www.biopharmawatch.com/news/BIIB/leqembi-subcutaneous-approval-china
BiopharmaWatch
en
2026-09-03T04:00:28.000Z
LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China
https://www.biopharmawatch.com/news/RVMD/phase-1-2-data-rasonque-nsclc
BiopharmaWatch
en
2026-09-02T21:50:00.000Z
New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer
https://www.biopharmawatch.com/news/SMMT/ivonescimab-harmoni-2-study-nsclc
BiopharmaWatch
en
2026-09-02T21:41:00.000Z
Ivonescimab Monotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in HARMONi-2 Study Conducted by Akeso in China
https://www.biopharmawatch.com/news/NVAX/novavax-september-investor-conferences-2026
BiopharmaWatch
en
2026-09-02T21:00:00.000Z
Novavax to Participate in September Investor Conferences
https://www.biopharmawatch.com/news/VNDA/vanda-pharmaceuticals-september-2026-investor-conferences
BiopharmaWatch
en
2026-09-02T20:51:00.000Z
Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences
https://www.biopharmawatch.com/news/JNJ/johnson-johnson-deutsche-bank-2026-healthcare-summit
BiopharmaWatch
en
2026-09-02T20:21:00.000Z
Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
https://www.biopharmawatch.com/news/EW/edwards-lifesciences-deutsche-bank-healthcare-summit
BiopharmaWatch
en
2026-09-02T20:15:00.000Z
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
https://www.biopharmawatch.com/news/SLBT/sl-science-holding-nasdaq-bell-ceremony
BiopharmaWatch
en
2026-09-02T20:10:00.000Z
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
https://www.biopharmawatch.com/news/RCEL/avita-medical-participate-lake-street-morgan-stanley-conferences
BiopharmaWatch
en
2026-09-02T20:10:00.000Z
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference
https://www.biopharmawatch.com/news/KARD/kardigan-present-september-investor-conferences
BiopharmaWatch
en
2026-09-02T20:05:00.000Z
Kardigan to Present at Two September Investor Conferences
https://www.biopharmawatch.com/news/SOLV/solventum-participate-wells-fargo-healthcare-conference
BiopharmaWatch
en
2026-09-02T20:05:00.000Z
Solventum to Participate in the 2026 Wells Fargo Healthcare Conference
https://www.biopharmawatch.com/news/IVA/inventiva-nativ3-phase-3-trial-lanifibranor-mash
BiopharmaWatch
en
2026-09-02T20:05:00.000Z
Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
https://www.biopharmawatch.com/news/BLLN/billiontoone-participate-wells-fargo-healthcare-conference
BiopharmaWatch
en
2026-09-02T20:05:00.000Z
BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference
https://www.biopharmawatch.com/news/NYXH/nyxoah-access-us-study-results-collapsed-patients
BiopharmaWatch
en
2026-09-02T20:05:00.000Z
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
https://www.biopharmawatch.com/news/SCTX/scribe-therapeutics-q2-2026-financial-results
BiopharmaWatch
en
2026-09-02T20:05:00.000Z
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
https://www.biopharmawatch.com/news/ELUT/elutia-participate-lake-street-hc-wainwright-conferences
BiopharmaWatch
en
2026-09-02T20:05:00.000Z
Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/STTK/shattuck-labs-september-investor-conferences
BiopharmaWatch
en
2026-09-02T20:05:00.000Z
Shattuck Labs Announces Participation in Upcoming September Investor Conferences
https://www.biopharmawatch.com/news/OPCH/option-care-health-investor-conferences-2026
BiopharmaWatch
en
2026-09-02T20:05:00.000Z
Option Care Health to Participate in Upcoming Investor Conferences
https://www.biopharmawatch.com/news/RARE/ultragenyx-phase-3-aspire-results-angelman-syndrome
BiopharmaWatch
en
2026-09-02T20:01:32.000Z
Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome
https://www.biopharmawatch.com/news/STAA/staar-surgical-appoints-ben-park-cto
BiopharmaWatch
en
2026-09-02T20:01:00.000Z
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer
https://www.biopharmawatch.com/news/XNCR/xencor-present-cantor-global-healthcare-conference-2026
BiopharmaWatch
en
2026-09-02T20:01:00.000Z
Xencor to Present at the 2026 Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/MIRM/mirum-pharmaceuticals-investor-conferences
BiopharmaWatch
en
2026-09-02T20:01:00.000Z
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
https://www.biopharmawatch.com/news/AMGN/amgen-presents-2026-wells-fargo-healthcare-conference
BiopharmaWatch
en
2026-09-02T20:01:00.000Z
AMGEN TO PRESENT AT THE 2026 WELLS FARGO HEALTHCARE CONFERENCE
https://www.biopharmawatch.com/news/NBIX/neurocrine-biosciences-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T20:01:00.000Z
Neurocrine Biosciences to Present at Upcoming Investor Conferences in September
https://www.biopharmawatch.com/news/SPRO/spero-therapeutics-presentation-hc-wainwright-conference
BiopharmaWatch
en
2026-09-02T20:01:00.000Z
Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/BDTX/black-diamond-therapeutics-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-02T20:01:00.000Z
Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/AURA/aura-biosciences-investor-conference-participation
BiopharmaWatch
en
2026-09-02T20:01:00.000Z
Aura Biosciences to Participate in Upcoming Investor Conference
https://www.biopharmawatch.com/news/ARQT/arcutis-management-morgan-stanley-conference-2026
BiopharmaWatch
en
2026-09-02T20:00:29.000Z
Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
https://www.biopharmawatch.com/news/VRDN/viridian-therapeutics-wells-fargo-healthcare-conference
BiopharmaWatch
en
2026-09-02T20:00:00.000Z
Viridian Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
https://www.biopharmawatch.com/news/ACET/adicet-bio-fireside-chat-hc-wainwright-conference
BiopharmaWatch
en
2026-09-02T20:00:00.000Z
Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/AVXL/anavex-regains-compliance-nasdaq-filing-requirement
BiopharmaWatch
en
2026-09-02T20:00:00.000Z
Anavex Life Sciences Regains Compliance with Nasdaq Periodic Filing Requirement
https://www.biopharmawatch.com/news/SLBT/sl-science-holding-nasdaq-debut
BiopharmaWatch
en
2026-09-02T19:00:11.000Z
SL Science Holding Limited 敲響納斯達克開市鐘，上市首季度業務成果豐碩
https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T18:42:00.000Z
Riassunto: SBC Medical parteciperà a diverse prossime conferenze per gli investitori nel settembre 2026
https://www.biopharmawatch.com/news/MVST/microvast-holdings-shareholder-losses-contact-law-firm
BiopharmaWatch
en
2026-09-02T18:34:28.143Z
Shareholders who lost money in shares of Microvast Holdings, Inc. (NASDAQ: MVST) Should Contact Wolf Haldenstein Immediately
https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T18:34:00.000Z
SBC Medical participera à plusieurs conférences d'investisseurs en septembre 2026
https://www.biopharmawatch.com/news/AARD/aardvark-therapeutics-shareholder-losses
BiopharmaWatch
en
2026-09-02T18:33:54.280Z
Shareholders who lost money in shares of acquired Aardvark Therapeutics, Inc. (NASDAQ: AARD) should contact Wolf Haldenstein Immediately
https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T18:22:00.000Z
Resumen: SBC Medical participará en varias conferencias para inversores en septiembre de 2026
https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T17:47:00.000Z
SBC Medical wird im September 2026 an mehreren bevorstehenden Investorenkonferenzen teilnehmen
https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T17:37:00.000Z
Samenvatting: SBC Medical neemt in september 2026 aan verschillende komende investeerdersconferenties deel
https://www.biopharmawatch.com/news/CWEB/charlottes-web-congressional-action-continuing-resolution
BiopharmaWatch
en
2026-09-02T15:07:00.000Z
Charlotte's Web Applauds Congressional Action to Advance Continuing Resolution
https://www.biopharmawatch.com/news/CYH/community-health-systems-wells-fargo-conference-2026
BiopharmaWatch
en
2026-09-02T15:00:00.000Z
Community Health Systems to Participate in the Wells Fargo 21st Annual Healthcare Conference
https://www.biopharmawatch.com/news/MOH/molina-healthcare-q3-2026-earnings-release
BiopharmaWatch
en
2026-09-02T13:00:00.000Z
Molina Healthcare Announces Third Quarter 2026 Earnings Release and Conference Call Dates
https://www.biopharmawatch.com/news/HCWB/hcw-biologics-strengthens-patent-hcw9302-alopecia-areata
BiopharmaWatch
en
2026-09-02T13:00:00.000Z
HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment
https://www.biopharmawatch.com/news/AIM/aim-immunotech-expands-ampligen-patent-protection-long-covid
BiopharmaWatch
en
2026-09-02T12:43:00.000Z
AIM ImmunoTech Significantly Expands Ampligen® Global Patent Estate with Long COVID Protection Across Europe and the United Kingdom Through 2041
https://www.biopharmawatch.com/news/NAGE/niagen-bioscience-longevity-investors-conference-2026
BiopharmaWatch
en
2026-09-02T12:32:00.000Z
Niagen Bioscience to Present at Longevity Investors Conference
https://www.biopharmawatch.com/news/COCH/envoy-medical-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
https://www.biopharmawatch.com/news/LQDA/liquidia-present-posters-ers-2026-congress
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress
https://www.biopharmawatch.com/news/DMAC/diamedica-therapeutics-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences
https://www.biopharmawatch.com/news/COR/cencora-accelerate-pharmacy-solutions-cell-gene-therapy
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
Cencora’s Accelerate Pharmacy Solutions Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs
https://www.biopharmawatch.com/news/CAI/caris-life-sciences-precision-oncology-iaslc-2026
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
https://www.biopharmawatch.com/news/HALO/halozyme-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
Halozyme to Participate at Upcoming Investor Conferences
https://www.biopharmawatch.com/news/ARTV/artiva-biotherapeutics-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
https://www.biopharmawatch.com/news/VERU/veru-fireside-chat-2026-cantor-conference
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
Veru to Participate in Fireside Chat at the 2026 Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/RNXT/renovorx-presentation-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th
https://www.biopharmawatch.com/news/FEED/envue-medical-exhibit-navigation-platform-vizient-exchange
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
https://www.biopharmawatch.com/news/SLS/sellas-life-sciences-sls009-preclinical-data-aacr-conference
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer
https://www.biopharmawatch.com/news/ALLO/allogene-therapeutics-cfo-retirement-geoffrey-parker
BiopharmaWatch
en
2026-09-02T12:30:00.000Z
Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker
https://www.biopharmawatch.com/news/SPRC/scisparc-neurothera-fda-orphan-drug-designation-tourette-syndrome
BiopharmaWatch
en
2026-09-02T12:17:00.000Z
SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
https://www.biopharmawatch.com/news/ACRV/acrivon-therapeutics-presentation-cantor-conference-2026
BiopharmaWatch
en
2026-09-02T12:00:28.000Z
Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/APPT/apptly-commences-trading-otcqb-dtc-eligible
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Apptly Commences Trading on the OTCQB and Becomes DTC Eligible
https://www.biopharmawatch.com/news/ARDT/ardent-health-expansion-specialty-care-ut-tyler
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine
https://www.biopharmawatch.com/news/THC/tenet-participate-wells-fargo-healthcare-conference
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Tenet to Participate in the Wells Fargo Healthcare Conference
https://www.biopharmawatch.com/news/ARGX/benchsci-argenx-agreement-preclinical-drug-discovery
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery
https://www.biopharmawatch.com/news/STOK/stoke-therapeutics-cantor-global-healthcare-conference
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Stoke Therapeutics to Present at the Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/ALNY/alnylam-webcast-presentations-september-conferences
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Alnylam to Webcast Presentations at Upcoming September Investor Conferences
https://www.biopharmawatch.com/news/SRRK/scholar-rock-fda-fast-track-apitegromab-fshd-phase-2
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (FSHD) Program as Participant Dosing Commences in Phase 2 FORGE Trial
https://www.biopharmawatch.com/news/SLN/silence-therapeutics-september-investor-conferences
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Silence Therapeutics to Participate in Three September Investor Conferences
https://www.biopharmawatch.com/news/RNA/atrium-therapeutics-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Atrium Therapeutics to Participate in Upcoming Investor Conferences
https://www.biopharmawatch.com/news/TRLV/trulieve-september-2026-event-participation
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Trulieve Announces September 2026 Event Participation
https://www.biopharmawatch.com/news/MDGL/madrigal-pharmaceuticals-2026-cantor-healthcare-conference
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Madrigal Pharmaceuticals to Participate in the 2026 Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/DSGN/design-therapeutics-2026-cantor-fitzgerald-conference
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Design Therapeutics to Participate in 2026 Cantor Fitzgerald Global Healthcare Conference
https://www.biopharmawatch.com/news/XAIR/beyond-air-participate-2026-cantor-healthcare-conference
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/ALGS/aligos-therapeutics-cantor-global-healthcare-conference
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/MIST/milestone-pharmaceuticals-investor-conferences-2026
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
https://www.biopharmawatch.com/news/IMDX/imdx-participate-lake-street-big10-conference
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
https://www.biopharmawatch.com/news/PRQR/proqr-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
ProQR to Participate in Upcoming Investor Conferences in September 2026
https://www.biopharmawatch.com/news/ALXO/alx-oncology-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
ALX Oncology to Present at Upcoming Investor Conferences in September
https://www.biopharmawatch.com/news/NAMS/newamsterdam-pharma-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September
https://www.biopharmawatch.com/news/ANNX/annexon-september-investor-conferences-2026
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Annexon to Participate in Upcoming September Investor Conferences
https://www.biopharmawatch.com/news/GERN/geron-present-upcoming-investor-conferences
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Geron to Present at Upcoming Investor Conferences
https://www.biopharmawatch.com/news/AAPG/ascentage-pharma-investor-conferences-2026
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
Ascentage Pharma to Participate in Four Upcoming Investor Conferences
https://www.biopharmawatch.com/news/VTVT/vtv-therapeutics-september-investor-conferences
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
vTv Therapeutics to Participate in September Investor Conferences
https://www.biopharmawatch.com/news/CGON/cg-oncology-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T12:00:00.000Z
CG Oncology to Present at Upcoming Investor Conferences in September
https://www.biopharmawatch.com/news/IMNM/immunome-presents-hc-wainwright-investment-conference
BiopharmaWatch
en
2026-09-02T11:45:00.000Z
Immunome to Present at the H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/PLRZ/polyrizon-completes-us-site-contracts-nasarix-allergy-study
BiopharmaWatch
en
2026-09-02T11:32:00.000Z
Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study
https://www.biopharmawatch.com/news/VSTM/verastem-oncology-september-investor-conferences
BiopharmaWatch
en
2026-09-02T11:30:00.000Z
Verastem Oncology to Participate in Upcoming September Investor Conferences
https://www.biopharmawatch.com/news/ZTS/zoetis-participate-morgan-stanley-healthcare-conference
BiopharmaWatch
en
2026-09-02T11:30:00.000Z
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
https://www.biopharmawatch.com/news/CRON/cronos-spinach-expands-edibles-vapes
BiopharmaWatch
en
2026-09-02T11:30:00.000Z
Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes
https://www.biopharmawatch.com/news/BBIO/bridgebio-new-data-infigratinib-achondroplasia-espe-2026
BiopharmaWatch
en
2026-09-02T11:30:00.000Z
BridgeBio to Present New Data on the Impact of Oral Infigratinib on Medical Complications in Achondroplasia at the Annual ESPE Meeting 2026
https://www.biopharmawatch.com/news/KYNB/kyntra-bio-presentation-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-02T11:30:00.000Z
Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/PVLA/palvella-therapeutics-investor-conferences-2026
BiopharmaWatch
en
2026-09-02T11:30:00.000Z
Palvella Therapeutics to Participate in Upcoming Healthcare Investor Conferences
https://www.biopharmawatch.com/news/ZVRA/zevra-therapeutics-investor-conferences-2026
BiopharmaWatch
en
2026-09-02T11:30:00.000Z
Zevra Therapeutics to Present at Upcoming Investor Conferences
https://www.biopharmawatch.com/news/CTSO/cytosorbents-reduces-severe-bleeding-cabg-patients
BiopharmaWatch
en
2026-09-02T11:28:00.000Z
CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings
https://www.biopharmawatch.com/news/ACB/reject-curaleaf-bid-aurora-cannabis
BiopharmaWatch
en
2026-09-02T11:05:00.000Z
Aurora Cannabis Urges Shareholders to REJECT Curaleaf's Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk
https://www.biopharmawatch.com/news/LFCR/lifecore-biomedical-agreement-commercial-site-transfer
BiopharmaWatch
en
2026-09-02T11:05:00.000Z
Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
https://www.biopharmawatch.com/news/QURE/uniqure-bla-ma-submission-huntingtons-disease
BiopharmaWatch
en
2026-09-02T11:05:00.000Z
uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
https://www.biopharmawatch.com/news/CANF/can-fite-namodenoson-phase-iii-liver-cancer-study
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
https://www.biopharmawatch.com/news/BLCO/bausch-lomb-envista-aspire-research
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
https://www.biopharmawatch.com/news/NVCR/novocure-upcoming-investor-events
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
Novocure Announces Upcoming Investor Events
https://www.biopharmawatch.com/news/UTHR/fda-acceptance-snda-nebulized-tyvaso-ipf
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis
https://www.biopharmawatch.com/news/NVS/alteogen-novartis-license-agreement-hybrozyme
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products
https://www.biopharmawatch.com/news/MAZE/maze-therapeutics-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
Maze Therapeutics to Participate in Three Upcoming Investor Conferences
https://www.biopharmawatch.com/news/TNXP/tonix-pharmaceuticals-cantor-2026-healthcare-conference
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
https://www.biopharmawatch.com/news/TCRX/tscan-therapeutics-strategic-reorganization-solid-tumors
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors
https://www.biopharmawatch.com/news/MDWD/mediwound-presents-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/LXEO/lexeo-therapeutics-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
https://www.biopharmawatch.com/news/CRDF/cardiff-oncology-participate-september-2026-conferences
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
Cardiff Oncology to Participate in September 2026 Conferences
https://www.biopharmawatch.com/news/EYPT/eyepoint-participation-investor-conferences-scientific-meeting
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting
https://www.biopharmawatch.com/news/FTRE/fortrea-acquires-early-phase-services-worldwide
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
https://www.biopharmawatch.com/news/IRD/opus-genetics-opgx-best1-clinical-data-presentation
BiopharmaWatch
en
2026-09-02T11:00:00.000Z
Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences
https://www.biopharmawatch.com/news/MRK/merck-participate-wells-fargo-healthcare-conference
BiopharmaWatch
en
2026-09-02T10:45:00.000Z
Merck to Participate in the Wells Fargo 21st Annual Healthcare Conference
https://www.biopharmawatch.com/news/IMUX/immunic-virtual-rd-day-relapsing-ms-september-2026
BiopharmaWatch
en
2026-09-02T10:30:00.000Z
Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
https://www.biopharmawatch.com/news/CMPS/compass-pathways-fierce-50-honoree-2026
BiopharmaWatch
en
2026-09-02T10:30:00.000Z
Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree
https://www.biopharmawatch.com/news/IMUX/immunic-virtual-rd-day-relapsing-ms-september-2026
BiopharmaWatch
en
2026-09-02T10:30:00.000Z
Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
https://www.biopharmawatch.com/news/ENSC/ensysce-biosciences-conference-participation
BiopharmaWatch
en
2026-09-02T08:30:00.000Z
Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
https://www.biopharmawatch.com/news/MDT/cornerstone-robotics-medtronic-partnership-robotic-surgery
BiopharmaWatch
en
2026-09-02T07:36:00.000Z
Cornerstone Robotics gibt strategische Partnerschaft mit Medtronic bekannt, um den weltweiten Zugang zu robotergestützter Chirurgie zu erweitern
https://www.biopharmawatch.com/news/PTGX/protagonist-therapeutics-investment-conferences-september-2026
BiopharmaWatch
en
2026-09-02T07:05:00.000Z
Protagonist Therapeutics to Participate in Two Investment Bank Conferences in September 2026
https://www.biopharmawatch.com/news/EVO/evotec-plectonic-collaboration-tcell-solid-tumors
BiopharmaWatch
en
2026-09-02T06:04:00.000Z
Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors
https://www.biopharmawatch.com/news/IPHA/innate-pharma-hc-wainwright-conference-2026
BiopharmaWatch
en
2026-09-02T05:00:00.000Z
Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/MDT/cornerstone-robotics-medtronic-strategic-alliance
BiopharmaWatch
en
2026-09-02T04:48:00.000Z
Cornerstone Robotics anuncia una alianza estratégica con Medtronic
https://www.biopharmawatch.com/news/MDT/cornerstone-robotics-medtronic-partnership-robotic-surgery
BiopharmaWatch
en
2026-09-02T02:45:00.000Z
Cornerstone Robotics ogłasza strategiczne partnerstwo z Medtronic mające na celu zwiększenie dostępu do chirurgii robotycznej na świecie
https://www.biopharmawatch.com/news/NUTX/nutex-health-data-breach-investigation
BiopharmaWatch
en
2026-09-02T01:56:00.000Z
Nutex Health Data Breach: Edelson Lechtzin LLP Investigates Theft of Patient and Employee Data
https://www.biopharmawatch.com/news/ZEPP/zepp-health-q2-2026-financial-results
BiopharmaWatch
en
2026-09-02T01:00:00.000Z
Zepp Health Corporation Reports Second Quarter of 2026 Unaudited Financial Results
https://www.biopharmawatch.com/news/ARLO/investigation-arlo-technologies-fiduciary-duties
BiopharmaWatch
en
2026-09-01T23:50:00.000Z
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Arlo Technologies, Inc. (NYSE: ARLO)
https://www.biopharmawatch.com/news/ONTO/investigation-onto-innovation-breach-fiduciary-duties
BiopharmaWatch
en
2026-09-01T23:50:00.000Z
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Onto Innovation Inc. (NYSE: ONTO)
https://www.biopharmawatch.com/news/TLX/telix-completes-enrollment-phase-3-bipass-study
BiopharmaWatch
en
2026-09-01T22:18:00.000Z
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
https://www.biopharmawatch.com/news/PNTG/pennant-group-2026-jefferies-healthcare-conference
BiopharmaWatch
en
2026-09-01T22:07:00.000Z
Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference
https://www.biopharmawatch.com/news/HWH/hwh-international-executive-leadership-transition
BiopharmaWatch
en
2026-09-01T21:27:00.000Z
HWH International Inc. Announces Executive Leadership Transition
https://www.biopharmawatch.com/news/ZRO/biosenta-mou-dynamic-facility-services-true-pilot
BiopharmaWatch
en
2026-09-01T21:13:00.000Z
Biosenta Enters into Memorandum of Understanding with Dynamic Facility Services for TRUE(TM) Pilot Program
https://www.biopharmawatch.com/news/MRVL/marvel-biosciences-grant-deferred-share-units
BiopharmaWatch
en
2026-09-01T21:01:00.000Z
Marvel Biosciences Announces Grant of Deferred Share Units
https://www.biopharmawatch.com/news/NPCE/neuropace-participate-2026-cantor-healthcare-conference
BiopharmaWatch
en
2026-09-01T21:01:00.000Z
NeuroPace to Participate in 2026 Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/ATYR/atyr-pharma-update-fda-response-phase-3-study-efzofitimod
BiopharmaWatch
en
2026-09-01T20:36:00.000Z
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
https://www.biopharmawatch.com/news/IBIO/ibio-participate-wells-fargo-healthcare-conference-2026
BiopharmaWatch
en
2026-09-01T20:30:00.000Z
iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
https://www.biopharmawatch.com/news/GRDN/guardian-pharmacy-acquires-nautilus-pharmacy-assets
BiopharmaWatch
en
2026-09-01T20:30:00.000Z
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
https://www.biopharmawatch.com/news/BRVE/braveheart-bio-cantor-global-healthcare-conference
BiopharmaWatch
en
2026-09-01T20:30:00.000Z
Braveheart Bio to Participate in Cantor Global Healthcare Conference
https://www.biopharmawatch.com/news/CLLS/cellectis-participation-upcoming-investor-conferences
BiopharmaWatch
en
2026-09-01T20:30:00.000Z
Cellectis Announces Participation in Upcoming Investor Conferences
https://www.biopharmawatch.com/news/PACS/pacs-group-acquires-32-facilities-florida
BiopharmaWatch
en
2026-09-01T20:15:00.000Z
PACS Group to Acquire Operations of 32 Facilities Across Florida and Closes on Additional Previously Announced Eduro Facilities
https://www.biopharmawatch.com/news/ANAB/anaptys-hc-wainwright-investment-conference-2026
BiopharmaWatch
en
2026-09-01T20:15:00.000Z
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/RARE/ultragenyx-genglycos-dtx401-trial-results
BiopharmaWatch
en
2026-09-01T20:05:14.000Z
Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journal of Inherited Metabolic Disease
https://www.biopharmawatch.com/news/MYO/myomo-presents-hc-wainwright-investment-conference
BiopharmaWatch
en
2026-09-01T20:05:00.000Z
Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference
https://www.biopharmawatch.com/news/EXEL/exelixis-webcast-fireside-chats-investor-conferences-september
BiopharmaWatch
en
2026-09-01T20:05:00.000Z
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September
https://www.biopharmawatch.com/news/SI/shoulder-innovations-morgan-stanley-conference-2026
BiopharmaWatch
en
2026-09-01T20:05:00.000Z
Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
https://www.biopharmawatch.com/news/INO/inovio-participate-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-01T20:05:00.000Z
INOVIO to Participate in Upcoming Investor Conferences
https://www.biopharmawatch.com/news/ALMR/alamar-biosciences-morgan-stanley-healthcare-conference
BiopharmaWatch
en
2026-09-01T20:05:00.000Z
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
https://www.biopharmawatch.com/news/BBOT/bbot-participate-investor-healthcare-conferences
BiopharmaWatch
en
2026-09-01T20:05:00.000Z
BBOT to Participate in Upcoming Investor Healthcare Conferences
https://www.biopharmawatch.com/news/LXRX/lexicon-pharmaceuticals-investor-conferences-2026
BiopharmaWatch
en
2026-09-01T20:05:00.000Z
Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences
https://www.biopharmawatch.com/news/SANA/sana-biotechnology-september-2026-investor-conferences
BiopharmaWatch
en
2026-09-01T20:05:00.000Z
Sana Biotechnology to Present at September 2026 Investor Conferences
https://www.biopharmawatch.com/news/SGHT/sight-sciences-morgan-stanley-conference-2026
BiopharmaWatch
en
2026-09-01T20:05:00.000Z
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15
https://www.biopharmawatch.com/news/ADPT/adaptive-biotechnologies-morgan-stanley-conference-2026
BiopharmaWatch
en
2026-09-01T20:05:00.000Z
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
https://www.biopharmawatch.com/news/CLGN/collplant-reverse-share-split-september-2026
BiopharmaWatch
en
2026-09-01T20:01:00.000Z
COLLPLANT ANNOUNCES REVERSE SHARE SPLIT
https://www.biopharmawatch.com/news/ARVN/arvinas-inducement-grant-nasdaq-rule-5635c4
BiopharmaWatch
en
2026-09-01T20:01:00.000Z
Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
https://www.biopharmawatch.com/news/RMT/royce-micro-cap-trust-third-quarter-distribution
BiopharmaWatch
en
2026-09-01T19:33:06.575Z
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Third Quarter Common Stock Distribution of $0.23 Per Share
https://www.biopharmawatch.com/news/SBC/sbc-medical-investor-conferences-september-2026
BiopharmaWatch
en
2026-09-01T17:35:00.000Z
SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026
https://www.biopharmawatch.com/news/KYTX/kyverna-miv-cel-safety-profile-update
BiopharmaWatch
en
2026-09-01T17:00:00.000Z
Company Statement on Miv-cel's Favorable Safety Profile
https://www.biopharmawatch.com/news/ONC/beone-medicines-partnership-us-government-cancer-therapy
BiopharmaWatch
en
2026-09-01T16:46:00.000Z
شركة BeOne Medicines تعلن عن إبرام اتفاقية طوعية مع الحكومة الأمريكية لتعزيز وتوسيع إمكانية الحصول على علاجات السرطان المُبتكرة
https://www.biopharmawatch.com/news/ONC/beone-medicines-us-agreement-cancer-drugs
BiopharmaWatch
en
2026-09-01T16:46:00.000Z
BeOne Medicines anuncia acordo voluntário com o governo dos EUA para expandir o acesso a medicamentos inovadores contra o câncer
https://www.biopharmawatch.com/news/ONC/beone-medicines-us-government-agreement-cancer-drugs
BiopharmaWatch
en
2026-09-01T16:46:00.000Z
BeOne Medicines anuncia un acuerdo voluntario con el Gobierno de EE. UU. para ampliar el acceso a medicamentos innovadores contra el cáncer
https://www.biopharmawatch.com/news/ONC/beone-medicines-us-agreement-oncology-drugs
BiopharmaWatch
en
2026-09-01T16:45:00.000Z
Riassunto: BeOne Medicines annuncia un accordo volontario con l'Amministrazione degli Stati Uniti per ampliare l'accesso a farmaci oncologici innovativi
https://www.biopharmawatch.com/news/ONC/beone-medicines-us-government-agreement-cancer-drugs
BiopharmaWatch
en
2026-09-01T16:45:00.000Z
BeOne Medicines gibt freiwillige Vereinbarung mit der US-Regierung bekannt, um den Zugang zu innovativen Krebsmedikamenten zu erweitern
https://www.biopharmawatch.com/news/ONC/beone-medicines-us-government-agreement-cancer-drugs
BiopharmaWatch
en
2026-09-01T16:45:00.000Z
Samenvatting: BeOne Medicines kondigt vrijwillige overeenkomst met Amerikaanse overheid aan om toegang tot innovatieve kankermedicijnen te vergroten
https://www.biopharmawatch.com/news/PNR/pnr-alert-hagens-berman-notifies-pentair-investors
BiopharmaWatch
en
2026-09-01T16:00:00.000Z
PNR Alert: Hagens Berman Notifies Pentair plc (NYSE: PNR) Investors of Expanded Class Period in New Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline
https://www.biopharmawatch.com/news/RVT/royce-small-cap-trust-declares-distribution
BiopharmaWatch
en
2026-09-01T15:40:00.000Z
Royce Small-Cap Trust, Inc. (NYSE: RVT) declares Third Quarter Common Stock Distribution of $0.33 Per Share
https://www.biopharmawatch.com/news/AZN/oral-pcsk9-inhibitor-market-growth-2026
BiopharmaWatch
en
2026-09-01T14:31:00.000Z
The Oral PCSK9 Inhibitor Market Enters High-Growth Phase Owing to the Approval of Merck's LIPFENDRA and the Emergence of Oral PCSK9 Inhibitor Drugs, Including, AstraZeneca's AZD0780, Aqur's AQR-008, and Others | DelveInsight
https://www.biopharmawatch.com/news/ONC/beone-medicines-phase-3-results-zihiera
BiopharmaWatch
en
2026-09-01T14:21:00.000Z
BeOne Medicines تعلن عن بيانات جديدة من المرحلة الثالثة حول معدلات البقاء على قيد الحياة، تعزّز الفوائد العلاجية للأنظمة الدوائية المحتوية على ZIIHERA لدى مرضى سرطان المعدة والمريء الإيجابي لمستقبل HER2+ في خط العلاج الأول
https://www.biopharmawatch.com/news/LLY/lilly-morgan-stanley-healthcare-conference-2026
BiopharmaWatch
en
2026-09-01T14:00:00.000Z
Lilly to participate in Morgan Stanley 24th Annual Global Healthcare Conference